DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

Information source: Phoenix Children's Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Disorder of Urinary Stent

Intervention: Tamsulosin (Drug); Oxybutynin (Drug)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Phoenix Children's Hospital

Overall contact:
Michael Nguyen, MD, Phone: (602) 933-5200, Email: mtn1023@hotmail.com

Summary

The primary objective of this study is to evaluate the efficacy and safety tamsulosin in reducing stent discomfort in the pediatric population in the peri-operative period. The secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in reducing stent discomfort.

Clinical Details

Official title: Randomized Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Discomfort in the Pediatric Population

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome:

Number of doses of pain in medication used

Pain scale based on the faces pain score

Eligibility

Minimum age: 4 Years. Maximum age: 18 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients aged 4-18 years will be enrolled in this study. We will include all patients

who will have a ureteral stent placement after their procedure. Exclusion Criteria:

- Patients with developmental delay or unable to verbalize their pain level will be

excluded.

Locations and Contacts

Michael Nguyen, MD, Phone: (602) 933-5200, Email: mtn1023@hotmail.com

Additional Information

Starting date: July 2015
Last updated: June 26, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017